Bogle Investment Management’s Surmodics SRDX Stock Holding History

Bogle Investment Management’s Portfolio SRDX Stock Details SRDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-11,696	Closed	-$390K	–	412
2020 Q1	$390K	Buy	+11,696	New	+$422K	0.04%	220
2019 Q2	–	Sell	-6,677	Closed	-$290K	–	331
2019 Q1	$290K	Buy	6,677 +232	+4%	+$11.8K	0.02%	254
2018 Q4	$305K	Sell	6,445 -55,946	-90%	-$3.36M	0.02%	298
2018 Q3	$4.66M	Buy	62,391 +4,314	+7%	+$297K	0.33%	102
2018 Q2	$3.21M	Buy	+58,077	New	+$2.68M	0.23%	122
2016 Q4	–	Sell	-41,317	Closed	-$1.24M	–	402
2016 Q3	$1.24M	Buy	41,317 +32,001	+344%	+$879K	0.09%	230
2016 Q2	$218K	Buy	+9,316	New	+$204K	0.02%	362
2015 Q2	–	Sell	-16,647	Closed	-$433K	–	420
2015 Q1	$433K	Buy	+16,647	New	+$397K	0.03%	298
2013 Q4	–	Sell	-9,329	Closed	-$221K	–	353
2013 Q3	$221K	Sell	9,329 -102,686	-92%	-$2.2M	0.02%	296
2013 Q2	$2.24M	Buy	+112,015	New	+$2.8M	0.27%	128

Other funds holding SRDX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Trigran Investments Northbrook, Illinois $545M AUM 56.2% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

Bogle Investment Management's SRDX Position: Q2 2020 in Review

Bogle Investment Management sold out of Surmodics (SRDX) in Q2 2020, closing a stake of 11,696 shares — an estimated $390K sold.

Bogle Investment Management first reported a position in SRDX in Q2 2013 and held it in 10 quarters. The position peaked at $4.66M in Q3 2018. 135 funds tracked by Wall St. Rank hold SRDX as of Q2 2020.

Bogle Investment Management reported no remaining Surmodics position as of Q2 2020 after selling out during the quarter.
Bogle Investment Management sold 11,696 Surmodics shares in Q2 2020, an estimated $390K.
Bogle Investment Management first reported a position in Surmodics in Q2 2013 and held it in 10 quarters.
Bogle Investment Management's Surmodics position peaked at $4.66M in Q3 2018.
135 funds tracked by Wall St. Rank held Surmodics as of Q2 2020.

Based on Bogle Investment Management's 13F filing for Q2 2020, filed 13 Aug 2020.